The Society for Immunotherapy of Cancer is the world’s leading member-driven organization dedicated to professionals working in the field of cancer immunotherapy. A non-profit organization, SITC was established in 1984 to advance the science, development, and application of tumour immunology and cancer immunotherapy. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality.
SITC stays dynamic in exploring both prescient and prognostic biomarkers of reaction in growth immunotherapy. In earlier years, SITC has centered endeavors in a few committed workshops and built up a progression of suggestions and in addition assets for analysts in the field. The SITC Immune Biomarkers Task Force was then reconvened in 2014 because of advances in disease immunotherapy, including positive results from clinical trials, new innovations to screen the insusceptible reaction, and rising competitor biomarkers from early stage trials.Read More»